CD4 and neoplasm: Results showed that B cells, CD4+T cells, macrophages, and myeloid DC cells were less abundant in the high-risk group, which suggested that cell cycle checkpoints-related genes may promote tumor progression by suppressing anti-tumor immune system activation (Figure 8F).